| 000 | 01749 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513175613.0 | ||
| 264 | 0 | _c19990622 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a1043-0342 | ||
| 024 | 7 |
_a10.1089/10430349950018418 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoç, O N | |
| 245 | 0 | 0 |
_aDeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. _h[electronic resource] |
| 260 |
_bHuman gene therapy _cApr 1999 |
||
| 300 |
_a1021-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xpharmacology |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aCarmustine _xpharmacology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aO(6)-Methylguanine-DNA Methyltransferase _xgenetics |
| 650 | 0 | 4 |
_aRetroviridae _xgenetics |
| 650 | 0 | 4 | _aTransduction, Genetic |
| 700 | 1 | _aReese, J S | |
| 700 | 1 | _aDavis, B M | |
| 700 | 1 | _aLiu, L | |
| 700 | 1 | _aMajczenko, K J | |
| 700 | 1 | _aGerson, S L | |
| 773 | 0 |
_tHuman gene therapy _gvol. 10 _gno. 6 _gp. 1021-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/10430349950018418 _zAvailable from publisher's website |
| 999 |
_c10182866 _d10182866 |
||